BF-168 is a candidate PET probe that specifically recognizes both neuritic and diffuse amyloid plaques in the brain, with high affinity for Aβ1-42 (Ki = 6.4 nM); it selectively labels senile plaques (SPs) and neurofibrillary tangles (NFTs) in Alzheimer’s disease (AD) brain tissue; in vivo studies demonstrate its ability to specifically label both compact and diffuse amyloid deposits in the brains of transgenic mouse models of AD; when radiolabeled with 18F, it shows high initial brain uptake and rapid clearance, making it suitable for amyloid imaging in positron emission tomography (PET).